Dose Ranging of GSK2336805 in Combination Therapy

Clinical trial NCT01648140 · COMPLETED

Trial details

NCT number: NCT01648140
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2012-08-01
Primary completion: 2014-07-01
Enrollment: 286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.